Nary a day goes by that the plaintiffs’ bar is not busily at work initiating a new mass tort action. Some cases expand on ...

Finally, Valisure raises the specter of opioid’s “arch-villain” Purdue: “GSK engaged in a massive, nationwide marketing campaign to convince doctors—and patients, for the first time ever—to use ...

In its latest statement, GSK reiterated its position that after “16 epidemiological studies looking at human data regarding the use of ranitidine, the scientific consensus is that there is no ...

The pharmaceutical giant reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and said its core outlook remained unchanged.

GSK (GSK) used its third-quarter trading update to draw a definitive line under the damaging litigation around its now discontinued heartburn medicine Zantac, by agreeing a settlement earlier in ...

“There are 16 epidemiological studies looking at human data regarding the use of ranitidine, including outcomes for more than 1 million patients using ranitidine, supporting this consensus.

Zantac was a popular medication used to treat heartburn, acid reflux, and related gastrointestinal issues. However, in 2019, the U.S. Food and Drug Administration (FDA) discovered that Zantac and ...

GSK PLC (GSK) reports robust year-to-date sales growth, driven by Specialty Medicines, while navigating vaccine sales ...

Belski is especially bullish on small- and mid-cap equities, calling them “the golden child of the next decade. I think that ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Proton pump inhibitors (PPIs) are widely used medications to manage common digestive issues like heartburn, acid reflux, and ...